Tag: Von Hippel-Lindau disease

Home / Von Hippel-Lindau disease

Categories

Belzutifan has been approved by the FDA for malignancies linked to von Hippel-Lindau disease

August 2021: Belzutifan (Welireg, Merck), a hypoxia-inducible factor inhibitor, has been approved by the Food and Drug Administration for adult patients with von Hippel-Lindau disease who require ther...
von-hippel-lindau-disease

Scan the code